178 related articles for article (PubMed ID: 28229968)
1. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status.
DE Oliveira DT; Savio AL; Marcondes JP; Barros TM; Barbosa LC; Salvadori DM; DA Silva GN
J Biosci; 2017 Mar; 42(1):91-101. PubMed ID: 28229968
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of urinary bladder cancer cell proliferation by silibinin.
Barros TMB; Lima APB; Almeida TC; da Silva GN
Environ Mol Mutagen; 2020 Apr; 61(4):445-455. PubMed ID: 32078183
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status.
Almeida TC; Guerra CCC; De Assis BLG; de Oliveira Aguiar Soares RD; Garcia CCM; Lima AA; da Silva GN
Environ Mol Mutagen; 2019 Oct; 60(8):740-751. PubMed ID: 31095781
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil).
Savio AL; da Silva GN; de Camargo EA; Salvadori DM
Mutat Res; 2014 Apr; 762():40-6. PubMed ID: 24625788
[TBL] [Abstract][Full Text] [Related]
5. Oral silibinin inhibits in vivo human bladder tumor xenograft growth involving down-regulation of survivin.
Singh RP; Tyagi A; Sharma G; Mohan S; Agarwal R
Clin Cancer Res; 2008 Jan; 14(1):300-8. PubMed ID: 18172282
[TBL] [Abstract][Full Text] [Related]
6. Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells.
Tyagi AK; Agarwal C; Singh RP; Shroyer KR; Glode LM; Agarwal R
Biochem Biophys Res Commun; 2003 Dec; 312(4):1178-84. PubMed ID: 14651997
[TBL] [Abstract][Full Text] [Related]
7. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
[TBL] [Abstract][Full Text] [Related]
8. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.
da Silva GN; Evangelista AF; Magalhães DA; Macedo C; Búfalo MC; Sakamoto-Hojo ET; Passos GA; Salvadori DM
Mol Biol Rep; 2011 Aug; 38(6):4159-70. PubMed ID: 21116856
[TBL] [Abstract][Full Text] [Related]
9. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bladder cancer cell proliferation by allyl isothiocyanate (mustard essential oil).
Sávio AL; da Silva GN; Salvadori DM
Mutat Res; 2015 Jan; 771():29-35. PubMed ID: 25771977
[TBL] [Abstract][Full Text] [Related]
11. No relationship between the amount of DNA damage and the level of hMLH1 and RASSF1A gene expression in bladder cancer cells treated with cisplatin and gemcitabine.
Camargo EA; da Silva GN; Gobette CP; Marcondes JP; Salvadori DM
Asian Pac J Cancer Prev; 2013; 14(10):5941-8. PubMed ID: 24289605
[TBL] [Abstract][Full Text] [Related]
12. Silibinin activates p53-caspase 2 pathway and causes caspase-mediated cleavage of Cip1/p21 in apoptosis induction in bladder transitional-cell papilloma RT4 cells: evidence for a regulatory loop between p53 and caspase 2.
Tyagi A; Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2006 Nov; 27(11):2269-80. PubMed ID: 16777994
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle arrest and apoptosis in TP53 subtypes of bladder carcinoma cell lines treated with cisplatin and gemcitabine.
da Silva GN; de Castro Marcondes JP; de Camargo EA; da Silva Passos Júnior GA; Sakamoto-Hojo ET; Salvadori DM
Exp Biol Med (Maywood); 2010 Jul; 235(7):814-24. PubMed ID: 20558835
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.
Yousefi M; Ghaffari SH; Soltani BM; Nafissi S; Momeny M; Zekri A; Behmanesh M; Alimoghaddam K; Ghavamzadeh A
Neurochem Res; 2012 Sep; 37(9):2053-63. PubMed ID: 22717697
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.
da Silva GN; de Camargo EA; Salvadori DM
Mol Biol Rep; 2012 Dec; 39(12):10373-82. PubMed ID: 23053941
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells.
Lima APB; Almeida TC; Barros TMB; Rocha LCM; Garcia CCM; da Silva GN
Mutagenesis; 2020 Aug; ():. PubMed ID: 32789469
[TBL] [Abstract][Full Text] [Related]
17. Silibinin attenuates TGF‑β1‑induced migration and invasion via EMT suppression and is associated with COX‑2 downregulation in bladder transitional cell carcinoma.
Li F; Sun Y; Jia J; Yang C; Tang X; Jin B; Wang K; Guo P; Ma Z; Chen Y; Wang X; Chang L; He D; Zeng J
Oncol Rep; 2018 Dec; 40(6):3543-3550. PubMed ID: 30272315
[TBL] [Abstract][Full Text] [Related]
18. Benzyl isothiocyanate suppresses IGF1R, FGFR3 and mTOR expression by upregulation of miR-99a-5p in human bladder cancer cells.
Lin JF; Tsai TF; Lin YC; Chen HE; Chou KY; Hwang TI
Int J Oncol; 2019 Jun; 54(6):2106-2116. PubMed ID: 30942430
[TBL] [Abstract][Full Text] [Related]
19. Tunneling Nanotubes Mediated microRNA-155 Intercellular Transportation Promotes Bladder Cancer Cells' Invasive and Proliferative Capacity.
Lu JJ; Yang WM; Li F; Zhu W; Chen Z
Int J Nanomedicine; 2019; 14():9731-9743. PubMed ID: 31849465
[TBL] [Abstract][Full Text] [Related]
20. FGFR3 and TP53 mutations in a prospective cohort of Belarusian bladder cancer patients.
Smal MP; Rolevich AI; Polyakov SL; Krasny SA; Goncharova RI
Exp Oncol; 2014 Dec; 36(4):246-51. PubMed ID: 25537218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
